MedTrace Logo

Relationship Between Apelin and New-onset Atrial Fibrillation After Coronary Artery Bypass Grafting

NCT02807532 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2016-06-21

No results posted yet for this study

Summary

To investigate whether apelin can be used as an indicator to predict postoperative atrial fibrillation in patients with coronary atherosclerotic heart disease, and to provide an objective basis for the clinical selection of a preventive intervention program for atrial fibrillation.

Conditions

  • Coronary Atherosclerotic Heart Disease

Interventions

OTHER

atrial fibrillation

In the case-control trial, patients with atrial fibrillation 7 days after surgery will be assigned to an atrial fibrillation group.

OTHER

non-atrial fibrillation

In the case-control trial, patients without atrial fibrillation 7 days after surgery will be assigned to a non-atrial fibrillation group.

Sponsors & Collaborators

  • General Hospital of Shenyang Military Region

    lead OTHER

Principal Investigators

  • Shu Xu, Master · The General Hospital of Shenyang Military Command, China

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2015-05-31
Completion
2015-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02807532 on ClinicalTrials.gov